Skip to main content

Neuroprotective effect of mivazerol, an α2-agonist, after transient forebrain ischemia in rats

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Background: 

We examined whether mivazerol, an α2-agonist, had neuroprotective effects after transient forebrain ischemia in rats. Methods: 

Male Sprague-Dawley rats, anesthetized with halothane, were assigned to one of four groups (n = 10 each): control (C, normal saline) and mivazerol 10 µg/kg (M10), 20 µg/kg (M20) and 40 µg/kg (M40) groups. Thirty minutes after drug administration, forebrain ischemia was induced with hemorrhagic hypotension and bilateral carotid artery occlusion for 10 min, and then the brain was reperfused. The neurologic outcome was evaluated 24 h, 48 h and 7 days after ischemia, followed by histologic evaluation. Results: 

The survival rate during 7 days was significantly lower in group M40 than in groups M10 and M20 (P < 0.05). The neurologic outcome was significantly better in groups M10 and M20 than in group M40 7 days after ischemia (P < 0.05). The number of intact neurons in hippocampal CA1 was significantly greater in group M20 than in the other groups (P < 0.05). Neuronal injury in the neocortex was significantly less in group M20 than in groups C and M40 (P < 0.05). Conclusions: 

Our results suggest that mivazerol, up to 20 µg/kg, provides neuroprotective effects, whereas 40 µg/kg may exaggerate neuronal injury after transient forebrain ischemia in rats.

Keywords: forebrain ischemia; mivazerol; neuroprotection; α2-agonist

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1399-6576.2005.00794.x

Affiliations: Department of Anesthesia and Intensive Care Medicine, Akita University School of Medicine, Akita, Japan

Publication date: September 1, 2005

mksg/aas/2005/00000049/00000008/art00014
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more